Dimensional Fund Advisors’s Immuneering IMRX Stock Holding History

Dimensional Fund Advisors’s Portfolio IMRX Stock Details IMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$103K	Hold	19,562	–	–	﹤0.01%	3116
2025 Q4	$129K	Hold	19,562	–	–	﹤0.01%	3125
2025 Q3	$137K	Buy	19,562 +6,196	+46%	+$32.2K	﹤0.01%	3161
2025 Q2	$45.2K	Hold	13,366	–	–	﹤0.01%	3240
2025 Q1	$20.4K	Hold	13,366	–	–	﹤0.01%	3304
2024 Q4	$29.4K	Hold	13,366	–	–	﹤0.01%	3318
2024 Q3	$33.4K	Hold	13,366	–	–	﹤0.01%	3321
2024 Q2	$17.2K	Sell	13,366 -17,983	-57%	-$29.6K	﹤0.01%	3357
2024 Q1	$90.6K	Buy	31,349 +14,665	+88%	+$82.2K	﹤0.01%	3269
2023 Q4	$123K	Hold	16,684	–	–	﹤0.01%	3259
2023 Q3	$128K	Buy	+16,684	New	+$153K	﹤0.01%	3287

Other funds holding IMRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OCM

Occam Crest Management Darien, Connecticut $165M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors's IMRX Position: Q1 2026 in Review

Dimensional Fund Advisors held its Immuneering (IMRX) position steady in Q1 2026 at 19,562 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #3116.

Dimensional Fund Advisors first reported a position in IMRX in Q3 2023 and has held it in 11 quarters since. The position peaked at $137K in Q3 2025. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

Dimensional Fund Advisors held 19,562 shares of Immuneering worth $103K as of Q1 2026.
Dimensional Fund Advisors left its Immuneering share count unchanged in Q1 2026.
Immuneering made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #3116 holding.
Dimensional Fund Advisors first reported a position in Immuneering in Q3 2023 and has held it in 11 quarters since.
Dimensional Fund Advisors's Immuneering position peaked at $137K in Q3 2025.
95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.